Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. (2020)
Attributed to:
Defining the metabolic phenotype of intracellular Mycobacterium tuberculosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-19959-4
PubMed Identifier: 33257709
Publication URI: http://europepmc.org/abstract/MED/33257709
Type: Journal Article/Review
Volume: 11
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723